Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oruka Therapeutics, Inc. | 1,131,954 | reported | 17 Sept 2025 | tx 6+786,000−160 |
| Viridian Therapeutics, Inc.\DE | 21,000 | reported | 01 Jul 2025 | tx 7+136,000 |
| Dianthus Therapeutics, Inc. /DE/ | 0 | reported | 27 Sept 2024 | tx 8+149,611−121,003 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Sept 2025 | GRANT_AWARD | Oruka Therapeutics, Inc. | 333,340 | 15.00 USD | |
| 01 Jul 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 21,000 | 0.00 USD | deriv |
| 02 Jun 2025 | GRANT_AWARD | Oruka Therapeutics, Inc. | 17,500 | 0.00 USD | deriv |
| 19 Nov 2024 | EXERCISE | Oruka Therapeutics, Inc. | 160,000 | — | |
| 19 Nov 2024 | EXERCISE | Oruka Therapeutics, Inc. | 160 | 0.00 USD | deriv |
| 27 Sept 2024 | OTHER | Dianthus Therapeutics, Inc. /DE/ | 62,146 | 0.00 USD | |
| 11 Sept 2024 | GRANT_AWARD | Oruka Therapeutics, Inc. | 275,000 | 23.00 USD | |
| 11 Sept 2024 | GRANT_AWARD | Oruka Therapeutics, Inc. | 160 | 23000.00 USD | deriv |
| 26 Jun 2024 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 21,000 | 0.00 USD | deriv |
| 01 Apr 2024 | OTHER | Dianthus Therapeutics, Inc. /DE/ | 58,857 | — | |
| 01 Apr 2024 | OTHER | Dianthus Therapeutics, Inc. /DE/ | 58,857 | — | |
| 26 Sept 2023 | PURCHASE | Dianthus Therapeutics, Inc. /DE/ | 30,000 | 13.15 USD | |
| 19 Sept 2023 | PURCHASE | Dianthus Therapeutics, Inc. /DE/ | 30,000 | 13.20 USD | |
| 13 Sept 2023 | PURCHASE | Dianthus Therapeutics, Inc. /DE/ | 9,367 | 11.76 USD | |
| 12 Sept 2023 | PURCHASE | Dianthus Therapeutics, Inc. /DE/ | 14,887 | 10.85 USD | |
| 11 Sept 2023 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 6,500 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 20,000 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 12,500 | 0.00 USD | deriv |
| 03 Jun 2021 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 12,500 | 0.00 USD | deriv |
| 04 Feb 2021 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 25,000 | 0.00 USD | deriv |
| 27 Oct 2020 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 24,000 | 0.00 USD | deriv |